PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
3986.96%
Revenue growth above 20% indicates exceptional top-line expansion. Peter Lynch would verify if this growth is sustainable and profitable. Cross-check Operating Margins.
No Data
No Data available this quarter, please select a different quarter.
804.39%
Gross profit growth above 25% indicates exceptional core profitability improvement. Warren Buffett would verify pricing power and cost control.
117.23%
Gross margin expansion above 5% indicates exceptional pricing power. Warren Buffett would verify competitive moat strength.
-19.33%
Negative R&D growth (spending reduction) needs careful analysis. Benjamin Graham would examine impact on competitive position.
-34.65%
Negative G&A growth (overhead reduction) needs verification. Benjamin Graham would examine impact on operations.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-24.37%
Negative operating expenses growth needs verification. Benjamin Graham would examine sustainability.
-24.37%
Negative total costs growth needs verification. Benjamin Graham would examine sustainability.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
36.46%
EBITDA growth above 15% demonstrates exceptional operating performance. Warren Buffett would verify sustainability.
98.45%
EBITDA margin growth above 5% demonstrates exceptional operational efficiency. Warren Buffett would verify sustainability.
35.83%
Operating income growth above 15% demonstrates exceptional core profitability. Warren Buffett would verify sustainability.
98.43%
Operating margin growth above 5% demonstrates exceptional efficiency gains. Warren Buffett would verify sustainability.
-7.89%
Negative other expenses growth needs verification. Benjamin Graham would examine sustainability.
35.97%
Pre-tax income growth above 15% demonstrates exceptional profitability improvement. Warren Buffett would verify sustainability.
98.43%
Pre-tax margin growth above 5% demonstrates exceptional cost management. Warren Buffett would verify sustainability.
No Data
No Data available this quarter, please select a different quarter.
36.40%
Net income growth above 15% demonstrates exceptional bottom-line expansion. Warren Buffett would verify sustainability.
98.44%
Net margin growth above 5% demonstrates exceptional profitability improvement. Warren Buffett would verify sustainability.
37.84%
EPS growth above 15% demonstrates exceptional shareholder value creation. Warren Buffett would verify sustainability.
37.84%
Diluted EPS growth above 15% demonstrates exceptional value creation despite potential dilution. Warren Buffett would verify sustainability.
2.81%
Share increase above 2% signals significant dilution. Seth Klarman would demand explanation.
2.81%
Diluted share increase above 2% signals significant dilution. Seth Klarman would demand explanation.